Moran Sean F.
Chief Financial Officer
Moran Sean F. has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.
On the most recent filing, Moran Sean F. is listed as Chief Financial Officer at Corbus Pharmaceuticals Holdings, Inc. Inside the rolling window, Moran Sean F. reported no open-market purchases and 3 open-market sales totaling $378K in CRBP. The largest disclosed transaction in the window is a sale of 12,981 CRBP shares on Oct 24, 2025, worth $221K.
Companies traded
Other insiders at CRBP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$378K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Moran Sean F. made?
Moran Sean F. has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Moran Sean F. trade?
Moran Sean F. has filed SEC Form 4 disclosures for 1 company, including CRBP.
When was Moran Sean F.'s most recent SEC Form 4 filing?
Moran Sean F.'s most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.
What is Moran Sean F.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Moran Sean F. is listed as Chief Financial Officer.
What is Moran Sean F.'s total buy and sell value in the current window?
Inside the rolling retention window, Moran Sean F. bought $0 and sold $378K based on SEC Form 4 filings.
What was Moran Sean F.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,981 CRBP shares on 2025-10-24, worth $221K, per SEC Form 4 filings.